Amgen, Inc. vs Occidental Petroleum Corporation — how do they compare? Amgen, Inc. trades at $412.21 (market cap $225.71B), while Occidental Petroleum Corporation trades at $58.54 (market cap $55.89B). The key difference: Amgen, Inc. is far larger — about 4× Occidental Petroleum Corporation's market cap, and Amgen, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| AMGN | OXY | |
|---|---|---|
Market Cap | $225.71B | $55.89B |
Sector | Health | Energy |
52-Week High | $417.20 | $66.24 |
52-Week Low | $271.18 | $38.92 |
Enterprise Value | $269.02B | $74.65B |
Dividend Yield | 2.42% | 2% |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →